Excision Biotherapeutics Appoints Sumathi Sivapalasingam, M.D, as Head of Translational Medicine

Excision appointed Sumathi Sivapalasingam as Head of Translational Medicine. Before, Sumathi was a Senior Director in Early Clinical Development and Experimental Sciences at Regeneron.

Excision Biotherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. It is based in Philadelphia, PA, and employs approximately 22 people.